Chinook Therapeutics
KDNY
$40.39
Share price
0.00%
Change (1 day)
109.71%
Change (1 year)
Categories
Earnings for Chinook Therapeutics (KDNY)
Earnings in 2023 (TTM): -$0.25 B
According to Chinook Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.25 B. In 2022 the company made an earning of -$0.19 B a decrease over its 2021 earnings that were of -$99.21 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Chinook Therapeutics from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.25 B | 33.53% |
| 2022 | -$0.19 B | 81.71% |
| 2021 | -$99.21 M | 24.73% |
| 2020 | -$79.54 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -53.98% | 🇺🇸 USA |